Suppr超能文献

血管内皮生长因子在成体中的作用。

Roles for VEGF in the adult.

作者信息

Maharaj Arindel S R, D'Amore Patricia A

机构信息

Schepens Eye Research Institute, 20 Staniford St., Boston, MA 02114, USA.

出版信息

Microvasc Res. 2007 Sep-Nov;74(2-3):100-13. doi: 10.1016/j.mvr.2007.03.004. Epub 2007 Apr 6.

Abstract

The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease preeclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies.

摘要

血管内皮生长因子(VEGF)在发育过程和病理学中的作用已广为人知,但其在正常成年组织中的功能却鲜为人知。在人类病理学中,针对VEGF使用抗血管生成疗法所带来的不良反应,已开始揭示VEGF在静止脉管系统中的潜在功能。来自VEGF及其受体在成体中的表达研究、子痫前期疾病以及实验性中和研究的进一步线索表明,VEGF参与内皮细胞存活和窗孔形成,以及非内皮细胞的信号传导和维持。VEGF的各种生化特性及其与其他生长因子的相互作用,可能是决定VEGF作为维持因子还是血管生成因子发挥作用的一个重要因素。深入了解VEGF在成体中的功能,可能会带来更有效的促血管生成和抗血管生成疗法。

相似文献

1
Roles for VEGF in the adult.
Microvasc Res. 2007 Sep-Nov;74(2-3):100-13. doi: 10.1016/j.mvr.2007.03.004. Epub 2007 Apr 6.
2
Therapeutic potential of manipulating VEGF splice isoforms in oncology.
Future Oncol. 2009 Jun;5(5):703-12. doi: 10.2217/fon.09.33.
3
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31.
4
VEGF in biological control.
J Cell Biochem. 2007 Dec 15;102(6):1358-67. doi: 10.1002/jcb.21579.
7
VEGF-targeted therapy: mechanisms of anti-tumour activity.
Nat Rev Cancer. 2008 Aug;8(8):579-91. doi: 10.1038/nrc2403. Epub 2008 Jul 3.
8
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
J Clin Oncol. 2005 Feb 10;23(5):1011-27. doi: 10.1200/JCO.2005.06.081. Epub 2004 Dec 7.
9
Targeting the vascular endothelial growth factor in hematologic malignancies.
Eur J Haematol. 2012 Nov;89(5):373-84. doi: 10.1111/ejh.12009. Epub 2012 Sep 20.
10
Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling.
J Ethnopharmacol. 2022 Jan 30;283:114667. doi: 10.1016/j.jep.2021.114667. Epub 2021 Sep 29.

引用本文的文献

3
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.
J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8.
9
MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway.
BMC Musculoskelet Disord. 2023 May 18;24(1):393. doi: 10.1186/s12891-023-06473-z.
10
Therapeutic angiogenesis based on injectable hydrogel for protein delivery in ischemic heart disease.
iScience. 2023 Apr 10;26(5):106577. doi: 10.1016/j.isci.2023.106577. eCollection 2023 May 19.

本文引用的文献

3
Sorafenib in advanced clear-cell renal-cell carcinoma.
N Engl J Med. 2007 Jan 11;356(2):125-34. doi: 10.1056/NEJMoa060655.
4
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
N Engl J Med. 2007 Jan 11;356(2):115-24. doi: 10.1056/NEJMoa065044.
6
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.
N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884.
7
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier.
Br J Ophthalmol. 2007 Apr;91(4):505-8. doi: 10.1136/bjo.2006.107417. Epub 2006 Dec 6.
8
Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events.
Semin Oncol. 2006 Oct;33(5 Suppl 10):S26-34. doi: 10.1053/j.seminoncol.2006.08.001.
10
Molecular mechanisms of VEGF-A action during tissue repair.
J Investig Dermatol Symp Proc. 2006 Sep;11(1):79-86. doi: 10.1038/sj.jidsymp.5650016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验